2016 (English)In: United European Gastroenterology journal, ISSN 2050-6406, E-ISSN 2050-6414, Vol. 5, no 1, 111-118 p.Article in journal (Refereed) Published
Background and objectives
The role of prophylactic pancreatic stenting (PS) in preventing post-endoscopic retrograde cholangio-pancreatography (ERCP) pancreatitis (PEP) has yet to be determined. Most previous studies show beneficial effects in reducing PEP when prophylactic pancreatic stents are used, especially in high-risk ERCP procedures. The present study aimed to address the use of PS in a nationwide register-based study in which the primary outcome was the prophylactic effect of PS in reducing PEP.
Place, publisher, year, edition, pages
2016. Vol. 5, no 1, 111-118 p.
ERCP, pancreatic stents, pancreatitis, complication rates, prophylaxis
IdentifiersURN: urn:nbn:se:umu:diva-132469DOI: 10.1177/2050640616645434OAI: oai:DiVA.org:umu-132469DiVA: diva2:1081748